[1] |
JIA Zhenzhen, HE Shuang, LI Yangyang, WEN Feifei, XU Xiaoyang, GUO Ningjie, WU Shuhua.
Correlations between expressions of DPD, LC3 and P62 in colorectal cancer and their clinical significance
[J]. China Oncology, 2022, 32(1): 24-33.
|
[2] |
MA Yifei , LIANG Xinjun , WEI Shaozhong .
Prognostic value of inflammatory and immune markers in resectable colorectal cancer
[J]. China Oncology, 2021, 31(9): 845-851.
|
[3] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[4] |
ZHANG Yingqiang , LIN Yansong .
Application and research progress of 90 Y microspheres internal radiation therapy in colorectal cancer with liver metastasis
[J]. China Oncology, 2021, 31(8): 762-768.
|
[5] |
XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia.
The advances in immunotherapy biomarkers of small cell lung cancer
[J]. China Oncology, 2021, 31(7): 635-639.
|
[6] |
HUA Qing, SHEN Xuefang, XU Pingbo .
Effect of KLK8 on apoptosis of colorectal cancer cells by regulating EGF and its mechanism
[J]. China Oncology, 2021, 31(5): 383-389.
|
[7] |
MA Weidong, WANG Tongtong, ZHU Qihang, YANG Haiou, LIN Dan.
Mechanism of colorectal cancer cell exosome-derived circ_0044366 in regulating release of MMP2 in fibroblasts and promoting metastasis of colorectal cancer
[J]. China Oncology, 2021, 31(5): 397-407.
|
[8] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[9] |
CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin.
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
[J]. China Oncology, 2021, 31(4): 330-334.
|
[10] |
CHEN Xinning , HUANG Fei , SHEN Minna , YANG Yihui , WANG Beili , GUO Wei .
Comparison of detection methods and analysis of influencing factors of somatic mutation in plasma of metastatic colorectal cancer patients
[J]. China Oncology, 2021, 31(3): 192-197.
|
[11] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[12] |
HE Hesheng , YANG Yuqiong , LIU Yinhua , JIN Xiaoke , XU Youhai , YAO Junping , LIU Shanhao , YAN Jiawei , HUANG Dongping .
Characteristic analysis of peripheral T-cell lymphoma associated with autoimmune hemolytic anemia
[J]. China Oncology, 2021, 31(2): 121-125.
|
[13] |
LI Lei , WANG Zhi , YOU Chunyuan .
The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report
[J]. China Oncology, 2021, 31(2): 156-160.
|
[14] |
LI Panpan, ZHANG Zhuo.
Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma
[J]. China Oncology, 2021, 31(12): 1194-1201.
|
[15] |
YU Yi, CONG Qing, XU Congjian, JIANG Wei.
The effect of PAFR on cisplatin sensitivity in ovarian cancer cells and its mechanism
[J]. China Oncology, 2021, 31(11): 1063-1071.
|